Ardelyx Inc. (NASDAQ:ARDX) saw an upside of 1.27% to close Monday at $3.18 after adding $0.04 on the day. The 5-day average trading volume is 8,974,360 shares of the company’s common stock. It has gained $3.43 in the past week and touched a new high 1 time within the past 5 days. An average of 9,430,050 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 12,654,484.
ARDX’s 1-month performance is 70.05% or $0.77 on its low of $2.14 reached on 12/29/22. The company’s shares have touched a 52-week low of $0.49 and high of $3.43, with the stock’s rally to the 52-week high happening on 01/17/23. YTD, ARDX has achieved 11.58% or $0.33 and has reached a new high 6 times. However, the current price is down -7.29% from the 52-week high price.
ARDX stock investors last saw insider trading activity on Nov 22.GRAMMER ELIZABETH A () most recently sold 1,242 shares at $1.95 per share on Nov 22. This transaction cost the insider $2,421. President & CEO, RAAB MICHAEL, sold 6,219 shares at a price of $1.95 on Nov 22. Then, on Nov 22, Chief Medical Officer Williams Laura A sold 1,241 shares at a price of $1.95 per share. This transaction amounted to $2,419.
ARDX stock has a beta of 1.16. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 58.01 while the price-to-book (PB) in the most recent quarter is 7.95.
Ardelyx Inc.’s quick ratio for the period ended June 29 was 2.30, with the current ratio over the same period at 2.30. In terms of profitability, the gross margin trailing 12 months is 89.40%. The firm’s gross profit as reported stood at $9.1 million against revenue of $10.1 million.
For the quarterly period ending June 29 this year, Ardelyx Inc.’s cash and short-term investments amounted to $29.0 million against total debt of $37.92 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -97.42% to -$22.89 million, while revenue of -$28.07 million was -22.63% off the previous quarter. Analysts expected ARDX to announce -$0.19 per share in earnings in its latest quarter, but it posted -$0.19, representing a 0.00% surprise. EBITDA for the quarter stood at more than -$21.6 million. ARDX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 77.81 million, with total debt at $37.92 million. Shareholders hold equity totaling $187.46 million.
Let’s look briefly at Ardelyx Inc. (ARDX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 61.48% to suggest the stock is trending Neutral, with historical volatility in this time period at 123.08%.
The stock’s 5-day moving average is $3.12, reflecting a +0.63% or $0.02 change from its current price. ARDX is currently trading +52.15% above its 20-day SMA, +214.85% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +127.14% and SMA200 by+171.79%.
Stochastic %K and %D was 61.27% and 67.15% and the average true range (ATR) pointed at 0.30. The RSI (14) points at 62.98%, while the 14-day stochastic is at 68.75% with the period’s ATR at 0.28. The stock’s 9-day MACD Oscillator is pointing at -0.04 and 0.06 on the 14-day charts.
In the most recent analyst report for Ardelyx Inc. (NASDAQ: ARDX), Piper Sandler upgraded it to an Overweight rating. They previously had a Neutral rating on the stock. Analysts offering their rating for ARDX stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate ARDX as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is ARDX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $3.00 and a high of $8.00, with their median price target at $6.50. Looking at these predictions, the average price target given by analysts is for Ardelyx Inc. (ARDX) stock is $5.75.